International and National Guidelines and Policy Documents on Viral Hepatitis

WHO Global Strategy for the Elimination of Viral Hepatitis B and C

National Strategy for Combating HIV/AIDS, Tuberculosis, and Viral Hepatitis for the Period up to 2030 (EN), approved by Resolution of the Cabinet of Ministers of Ukraine No. 1415-r dated November 27, 2019

WHO Operational Guidance 2024: Priority Areas for Human-Centered Planning of Hepatitis B and C Testing Services

• Recommendations for Testing for Viral Hepatitis B and C within Primary Health Care Services Using Rapid Tests

• Order of the Ministry of Health of Ukraine No. 504 dated March 19, 2018, Annex 3 to the Procedure for the Provision of Primary Health Care (Section II, Paragraph 2)

• Viral Hepatitis B. Evidence-Based Clinical Guidelines, 2020
• Standard of Medical Care. Viral Hepatitis B in Children, 2025 (Order of the Ministry of Health of Ukraine No. 165 of January 27, 2025)

• Standard of Medical Care. Viral Hepatitis B in Adults, 2025 (Order of the Ministry of Health of Ukraine No. 165 of January 27, 2025)

• EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection
• WHO Guidelines for the prevention, diagnosis, care, and treatment of people with chronic hepatitis B infection (March 29, 2024)

• Standard of Medical Care. Viral Hepatitis C in Children, 2025 (Order of the Ministry of Health of Ukraine No. 1178 dated July 23, 2025)
• Standard of Medical Care. Viral Hepatitis C in Adults, 2025 (Order of the Ministry of Health of Ukraine No. 1178 dated July 23, 2025)
• Viral Hepatitis C. Evidence-Based Clinical Guidelines, 2020
• WHO Recommendations on the Treatment of Chronic Hepatitis C, October 17, 2022

• EASL Clinical Practice Guidelines, Viral Hepatitis C 2020

• Updated in 2023: Recommendations for testing, management, and treatment of hepatitis C virus infection from the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA). 

• EASL Clinical Practice Guidelines on Hepatitis Delta Virus 2023
• Liverpool Drug Interaction Table  
• Assessment of liver damage using the APRI and FIB-4 indices

Links to useful resources:

Public Health Center of the Ministry of Health of Ukraine 

WHO 

Global Alliance for Hepatitis 

EASL (European Association for the Study of the Liver) 

AASLD American Association for the Study of Liver Diseases 

IDSA Infectious Diseases Society of America 

CDC: U.S. Centers for Disease Control and Prevention

 

NICE National Institute for Health and Care Excellence 

VHPB Viral Hepatitis Prevention Board